Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

Completed · Phase 4 · Has a placebo group

Conditions studied: Cognition in Schizophrenia

In brief

This research is being done because people with schizophrenia often have problems with thinking including learning, remembering, paying attention, and problem solving. During this study, we will test if cognitive remediation (computer games made to improve thinking), used along with a drug called atomoxetine, may help the problems in thinking as well as some of the symptoms of schizophrenia.

Key facts

Study ID
NCT00628394
Run by
University of Texas Southwestern Medical Center
People needed
119
Starts
2003-09-01
Expected to finish
2011-02-01
Last updated by the study team
2020-09-25

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.